What COGNIFAI LTD does

CognifAI Ltd is a privately held AI solutions provider headquartered in Ahmedabad, India, founded in 2023. The company develops customized AI platforms primarily for life sciences, healthcare, and regulated industry clients, operating with a lean team of 11–50 employees under a founder-led management structure (CEO Hemang Naik, COO/Strategy Diana Priyadharshini, CTO Romesh Sheth, and CCO Jai Desai). Its core product portfolio centers on two flagship solutions — CoVigilAI, a generative AI-powered medical literature monitoring platform for pharmacovigilance — and CliniWiseAI, a multi-module clinical trial management suite covering eProtocol Creation, eCRF/eCSR Generation, Patient Narrative, Automated Data Extraction, PHI Redaction, eSDV Assistant, and Chat with Citation. The portfolio extends laterally into AccuLitAI (scholarly publishing validation), Label Validation (regulatory compliance for pharma/CPG/retail), Digital Human Studio (avatar-based customer engagement), and an AI-enabled Onboarding Solution, all built on the proprietary SyntropIQ-AI Framework.

Underlying technology spans Generative AI, Agentic AI, Custom LLM Models, Conversational AI, NLP, and computer vision (OCR for DICOM/JOG medical imaging with PHI redaction). The company holds ISO 9001:2015 (Quality Management) and ISO 27001:2022 (Information Security) certifications — relevant procurement credentials for regulated pharmaceutical and healthcare buyers.

Revenue is generated through professional services (custom AI consulting and implementation projects) and recurring AI support and maintenance subscriptions, with quote-based pricing and no public price list. Go-to-market is sales-led with direct enterprise engagement, supplemented by channel partnerships — most notably a flagship alliance with Ennov, a life sciences compliance platform serving 500+ companies and 150,000 users globally, into which CoVigilAI is integrated. The company claims worldwide service delivery with existing EMEA penetration evidenced by a European CRO customer testimonial. No external funding rounds, revenue figures, or M&A activity have been disclosed.

Name

COGNIFAI LTD

Legal name

CognifAI Ltd

Website

https://cognifai.in

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

CognifAI Ltd is an India-based AI solutions company that develops customized generative AI, agentic AI, and custom LLM platforms for life sciences, healthcare, and regulated industries, with flagship products CoVigilAI for pharmacovigilance literature monitoring and CliniWiseAI for clinical trial management, sold to enterprise clients via direct sales and channel partnerships.

Ownership category

akta.pro rank

Product category

Enterprise AI Software for Life Sciences & Healthcare

NAICS

Software Publishers (5132), Custom Computer Programming Services (541511), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Prepackaged Software (7372), Services-Management Consulting Services (8742), Services-Computer Programming Services (7371)

akta.pro primary industry

AI/ML Engineering & Model Development Services (BPAEAHAF)

akta.pro secondary industries

AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

Keywords

• Enterprise AI solutions
• Pharmacovigilance automation
• Clinical trial AI
• Agentic AI platform
• Custom LLM development

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Customized AI Solutions & Consulting: CognifAI offers customized AI solutions tailored to individual business needs, providing AI strategy consulting, implementation, and ongoing support services. Revenue is generated through project-based engagements and consulting fees for designing and delivering AI solutions.
2. AI Services Subscriptions: Ongoing AI support and maintenance services including monitoring, troubleshooting, updates, upgrades, and optimization. This provides recurring revenue through continuous engagement with clients.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

CognifAI designs, develops, and deploys customized AI solutions for enterprises, with a primary focus on life sciences, healthcare, and clinical research workflows. Its core commercial offerings are the CoVigilAI pharmacovigilance literature monitoring platform and the CliniWiseAI clinical trial management suite, complemented by AccuLitAI research paper validation, Label Validation, Digital Human Studio, an AI-enabled onboarding solution, and a portfolio of Generative AI, Agentic AI, Custom LLM, and Conversational AI services delivered on its SyntropIQ-AI Framework.

Product overview

CognifAI offers a portfolio of AI-powered products organized around a platform and modular solutions architecture. The core product portfolio includes CoVigilAI (generative AI-powered pharmacovigilance literature monitoring) and CliniWiseAI (comprehensive clinical trial management with multiple AI-powered modules including eProtocol Creation, eCRF/eCSR Generation, Patient Narrative, Automated Data Extraction, PHI Redaction, eSDV Assistant, and Chat with Citation). Additional specialized solutions include AccuLitAI (research paper validation for scholarly publishing), Label Validation Solution (regulatory label compliance), Digital Human Studio (custom avatar creation), and AI-enabled Onboarding Solution (customer segmentation and retention). Services encompass Generative AI Consulting, AI Strategy & Consulting, Conversational AI, Agentic AI Solutions, Custom LLM Models, AI Support & Maintenance, and Digital Human implementation—all built on the SyntropIQ-AI Framework. The company serves life sciences, healthcare, banking, financial services, and regulated industries.

Differentiator

Problem solved

Functional benefit

Brands

• CoVigilAI: AI-powered medical literature monitoring solution for pharmacovigilance, supporting Sponsors, Marketing Authorization Holders, and Applicants in navigating regulatory requirements in pharmacovigilance, veterinary pharmacovigilance, materiovigilance, cosmetovigilance, and nutravigilance.
• CliniWiseAI
• AccuLitAI
• Label Validation Solution
• Digital Human Studio
• SyntropIQ-AI Framework

Products and services

• CliniWiseAI AI-powered clinical trial management solution that integrates AI and ML throughout all stages of clinical trials, featuring modules for eProtocol Creation, eCRF/eCSR Generation, Patient Narrative, Automated Data Extraction, PHI Redaction, eSDV Assistant, and Chat with Citation for sponsors, CROs, and clinical research teams.
• CoVigilAI Generative AI-powered medical literature monitoring solution for pharmacovigilance that provides real-time analysis and intelligent knowledge management for drug safety monitoring across pharmaceutical, veterinary, materiovigilance, cosmetovigilance, and nutravigilance.
• AccuLitAI AI-driven research paper validation solution for scholarly publishing houses that assesses research papers using generative AI to ensure structural integrity, formatting compliance, and alignment with publishing guidelines.
• Label Validation Solution Generative AI-powered label validation solution that instantly analyzes product labels to identify compliance with complex regulatory guidance across pharmaceutical, CPG, retail, and regulated industries.
• Digital Human Studio AI-powered platform that enables creation of custom avatars that look, move, talk, and engage in conversations using conversational AI for customer service, education, and entertainment applications.
• AI-enabled Onboarding Solution AI-powered customer onboarding platform that utilizes advanced AI models for customer segmentation and provides actionable insights on customer retention strategies.
• Generative AI Consulting Expert consulting services covering the full Generative AI implementation journey from model selection to customization for unique business data and goals across life sciences, healthcare, and financial services.
• AI Strategy & Consulting Strategic consulting services that bridge organizational gaps in AI adoption, integrating AI across operations with focus on decision intelligence, digital transformation, performance design, and automation.
• Conversational AI Service Generative AI-enabled conversational AI solution providing 24/7 customer support with real-time, personalized responses for banking services, regulatory compliance guidance, and customer rights inquiries.
• Agentic AI Solutions Service Enterprise AI solutions featuring autonomous agents that understand context, make independent decisions, and manage complex processes with capabilities for 24x7 availability, autonomous decision-making, and adaptive learning.
• Custom LLM Models Service Enterprise-grade large language model development built around unique business requirements, enabling highly accurate natural language understanding, personalized AI-driven conversations, and secure handling of sensitive data.
• AI Support & Maintenance Service Comprehensive AI system support including monitoring, troubleshooting, updates, upgrades, ongoing optimization, continuous learning, and modernization services.
• Digital Human Service Creation and implementation of digital humans using advanced AI, NLP, and machine learning technologies, integrated into sales, marketing, and customer service workflows.
• SyntropIQ-AI Framework AI framework referenced as part of CognifAI's ecosystem that underpins the company's generative and agentic AI offerings, with detailed capabilities hosted at syntropiq-ai.com.

Quantifiable outcome

• 70% reduction in operating costs with tailored AI solutions
• +11 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature11 records

Partnerships

One partnership is on record.

• EnnovflagshipStrategic or Co-development PartnerEnnov, a leading provider of unified compliance software solutions for Life Sciences, aims to integrate CognifAI's advanced AI-driven literature monitoring solution, CoVigilAI, into Ennov's comprehensive Pharmacovigilance offering. Ennov provides cloud-based solutions covering Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Document Management, serving over 500 companies and 150,000 users worldwide.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Deep 6 AI: Deep 6 AI uses AI to accelerate clinical trial patient recruitment and trial design. It is an emerging competitor in the AI-for-clinical-trials space where CliniWiseAI operates.
• Unlearn.AI: Unlearn.AI applies AI to clinical trial design and synthetic control arms. It is an emerging competitor in AI-augmented clinical operations, comparable to CognifAI's CliniWiseAI vision.

Direct peers

• ArisGlobal: ArisGlobal's LifeSphere platform includes pharmacovigilance, regulatory, and clinical safety modules. It overlaps directly with CognifAI's CoVigilAI and is a peer in AI-augmented drug safety and literature monitoring.
• Saama Technologies: Saama applies AI/ML to clinical development, commercial, and real-world data for life sciences. It is a direct competitor in AI-driven clinical trial and pharmacovigilance intelligence, serving overlapping pharma and CRO customers.
• Linguamatics (an IQVIA company): Linguamatics provides NLP-based text mining for biomedical literature, clinical, and regulatory use cases. It directly competes with CognifAI's CoVigilAI for medical literature monitoring and pharmacovigilance.
• Yseop: Yseop builds AI/NLP assistants for regulatory and medical writing automation in life sciences, including clinical study report generation. It competes with CliniWiseAI's eCRF/eCSR generation capability.

Broad incumbents

• ICON plc: ICON is a global CRO with growing AI/analytics capabilities for clinical trial operations. It represents a broad incumbent alternative for pharma clients evaluating AI-backed clinical service providers.
• IQVIA: IQVIA is a global clinical research and life sciences data services company with substantial AI capabilities for clinical trials and commercial analytics. It competes broadly with CognifAI in AI-enabled clinical operations and real-world evidence.
• Veeva Systems: Veeva provides cloud software including clinical, regulatory, and quality solutions for life sciences. Its broader platform competes with CognifAI's CliniWiseAI and label validation offerings at the suite level rather than at the AI-native point solution level.

Others

• Ennov: Ennov is both a partner and a complementary platform for regulatory, pharmacovigilance, quality, and clinical document management. It is included as a peer because it competes in the same pharma compliance space and is a strategic channel for CognifAI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cognifai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COGNIFAI LTD